About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

Examples of EPO applications set aside, modified or withdrawn based on TKDL evidence

(Information courtesy of the Council of Scientific and Industrial Research)

Earlier intention to grant a patent set aside by EPO:

  • EP1520585: EPO decided to grant patent to M/s. Data Medica, Padova SPA, Italy on 19.2.2009 for use of Pista as an anti-cancer drug. Evidence submitted by TKDL Unit, CSIR, India on 09.07.2009, based upon which the EPO set aside its earlier intention to grant patent on 14.07.2009.
  • EP1747786: EPO decided to grant patent to M/s. Perdix Eurogroup SL, Spain on 02.04.2009 for use of watery extract of Kharbooza /melon as an anti-vitilgo cream. Evidence submitted by TKDL Unit, CSIR, India on 08.07.2009, based upon which the EPO set aside its earlier intention to grant patent on 28.7.2009.

Claims of the application modified the applicant:

  • EP1849473: EPO decided to grant patent to M/s. Livzon Pharmaceutical Group Inc., China on 25.02.2010 for use of Kalamegha and Mint for the treatment of avian influenza. Evidence submitted by TKDL Unit, CSIR, India on 20.05.2010, based upon which the EPO set aside its earlier intention to grant patent on 10.6.2010. Subsequently M/s. Livzon Pharmaceutical Group Inc modified its claims on 05.07.2010 in the independent use of Kalamegha and Mint for the treatment of avian influenza.

Claims/applications withdrawn by the applicant:

  • EP1781309: M/s Purimed Co. LTD., Korea filed a patent application on 09-06-2005 for treatment of heart diseases using Indian lotus. Evidence submitted by TKDL Unit, CSIR, India on 17-07-2009. On 04-08-2009 applicant decided to withdraw its claims / patent application.
  • EP1807098: M/s Amcod Limited, Kenya filed a patent application on13-09-2005 for treatment of diabetes using Neem, Gheekawaar and Daal Chini. Evidence submitted by TKDL Unit, CSIR, India on 01-07-2009. On 24-11-2009 applicant decided to withdraw its claims / patent application.
  • EP2116253: M/s Phytrix JV, LLC, USA, filed a patent application on 07.05.2008 using Phyllanthus / Bhumi aamla for the treatment of HIV associated diseases. Evidence submitted by TKDL Unit, CSIR, India on 03.08.2010. On 28-09-2010 applicant decided to withdraw its claims / patent application.
  • EP1971354: M/s Seoul National University Industry Foundation, Korea, filed a patent application on 05.01.2007 using licorice / Mulaithi for the treatment of liver diseases. Evidence submitted by TKDL Unit, CSIR, India on 04.05.2010. On 21-10-2010 applicant decided to withdraw its claims / patent application.

 

https://www3.wipo.int/contact/en/area.jsp?area=meetings https://www.wipo.int/pressroom/en/ https://www.wipo.int/tools/en/disclaim.html https://www.wipo.int/en/web/privacy-policy/ https://www.wipo.int/en/web/accessibility/ https://www.wipo.int/tools/en/sitemap.html https://www3.wipo.int/newsletters/en/ https://www.wipo.int/en/web/podcasts/ https://www.wipo.int/news/en/